Enough new-generation anthrax vaccine to dose 25 million people: That’s first on the government’s shopping list under a massive new program to develop and stockpile antidotes to biological and chemical weapons. Called Project BioShield, the $5.6 billion program passed the House on a 414-2 vote Wednesday. The Senate passed it in May and President Bush (news - web sites)'s signature is guaranteed. Federal health officials have their wish-list ready: antidotes for botulism and anthrax, a safer smallpox vaccine, and a long-awaited children’s version of an anti-radiation pill.